Last reviewed · How we verify

NCT03209843: PERFECTO

Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)

Completed NA Last updated 14 April 2021
What this trial tests

NA trial testing Percutaneous recanalization of chronic total occlusion in Chronic Total Occlusion of Coronary Artery in 122 participants. Completed in 12 February 2021.

Timeline
7 March 2018
Primary endpoint
12 February 2021
12 February 2021

Quick facts

Lead sponsorPoitiers University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment122
Start date7 March 2018
Primary completion12 February 2021
Estimated completion12 February 2021
Sites7 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Poitiers University Hospital

Who can join

18 and older, any sex, with Chronic Total Occlusion of Coronary Artery or Optical Coherence Tomography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of PERFECTO is to assess the reendothelialization at 3 months after successfully CTO percutaneous intervention (PCI) with new generation drug eluting stent (DES) by OFDI analysis. Designed as a multicentric, observational and prospective study which will be conducted at University Hospital of Poitiers (France), a systematic OFDI analysis will be realized immediately after CTO-PCI and at 3 months. Known as major predictive factors of stent thrombosis, percentages of malapposition, uncovered struts and neointimal hyperplasia proliferation will be measured over the entire length of each stent implanted combining in a composite primary endpoint.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Optical Coherence Tomography to Better Assess Chronic Total Occlusion Percutaneous Intervention Results: The PERFECTO Study.
    Levesque S, Faurie B, Lattuca B, Lemoine J, et al · · 2025 · PMID 40930013 · DOI 10.1016/j.jacadv.2025.102125

Verify or expand the search:

Other recruiting trials for Chronic Total Occlusion of Coronary Artery

Currently open trials in the same condition.

Other Poitiers University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03209843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing